Skip to content

Author

W. Parichatikanond

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling.

Apoptosis and mitochondrial bioenergetic dysfunction are hallmarks of cardiotoxicity that drive cardiac damage, particularly following exposure to chemotherapeutic agents such as doxorubicin. Doxorubicin induces pro-apoptotic signaling and disrupts mitochondrial homeostasis and cellular energy metabolism, leading to ca...

Hnin Ei Ei Khine, Supachoke Mangmool, Warisara Parichatikanond · 0 citations
Review Open access Aug 2026

Adenosine A2A and A2B Receptors as Therapeutic Targets in Cardiovascular Diseases: Mechanistic Insights and Clinical Prospects

Adenosine is a ubiquitous endogenous modulator that coordinates diverse physiological processes by binding to specific adenosine receptors (ARs). Among the four known AR subtypes, A2ARs and A2BRs are critical determinants of cardiovascular homeostasis. This narrative review comprehensively synthesizes current knowled...

Warisara Parichatikanond, Ratchanee Duangrat, N. Nuamnaichati et al. · 0 citations
Open access Jul 2026

Chemical Constituents of Aerides odorata and Their Anti-Neuroinflammatory Effects on LPS-Activated BV2Microglial Cells

Comprehensive phytochemical study of the whole plants of Aerides odorata yielded 21 compounds, including two new phenanthrene derivatives (1–2), one new inseparable enantiomeric aurone glycoside (3) and 18 known compounds (4–21). The structures of the new compounds were elucidated by extensive spectroscopic analyses, e...

M. Thant, Virunh Kongkatitham, H. Khine et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.